Immunosenescence in neurocritical care

被引:4
|
作者
Inoue, Shigeaki [1 ]
Saito, Masafumi [1 ]
Kotani, Joji [1 ]
机构
[1] Kobe Univ, Dept Disaster & Emergency Med, Grad Sch Med, Kusunoki Cho 7-5-2,Chuo Ward, Kobe, Hyogo 6500017, Japan
来源
关键词
Sepsis; Elderly; Immunosenescence; Immune paralysis; REGULATORY T-CELLS; BLOOD-BRAIN-BARRIER; ISCHEMIC-STROKE; ANTIBODY-RESPONSE; IMPACT; EXPRESSION; SEPSIS; IMMUNODEPRESSION; ENCEPHALOPATHY; ACTIVATION;
D O I
10.1186/s40560-018-0333-5
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BackgroundSeveral advanced and developing countries are now entering a superaged society, in which the percentage of elderly people exceeds 20% of the total population. In such an aging society, the number of age-related diseases such as malignant tumors, diabetes, and severe infections including sepsis is increasing, and patients with such disorders often find themselves in the ICU.Main bodyAge-related diseases are closely related to age-induced immune dysfunction, by which reductions in the efficiency and specificity of the immune system are collectively termed immunosenescence. The most noticeable is a decline in the antigen-specific acquired immune response. The exhaustion of T cells in elderly sepsis is related to an increase in nosocomial infections after septicemia, and even death over subacute periods. Another characteristic is that senescent cells that accumulate in body tissues over time cause chronic inflammation through the secretion of proinflammatory cytokines, termed senescence-associated secretory phenotype. Chronic inflammation associated with aging has been called inflammaging, and similar age-related diseases are becoming an urgent social problem.ConclusionIn neuro ICUs, several neuro-related diseases including stroke and sepsis-associated encephalopathy are related to immunosenescence and neuroinflammation in the elderly. Several advanced countries with superaged societies face the new challenge of improving the long-term prognosis of neurocritical patients.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Nutrition in neurocritical care
    Azim, Afzal
    Ahmed, Armin
    NEUROLOGY INDIA, 2016, 64 (01) : 105 - 114
  • [32] Neurocritical care update
    Kuroda Y.
    Journal of Intensive Care, 4 (1)
  • [33] Osmotherapy in neurocritical care
    Bhardwaj, Anish
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2007, 7 (06) : 513 - 521
  • [34] Geographic Access to US Neurocritical Care Units Registered with the Neurocritical Care Society
    Ward, Michael J.
    Shutter, Lori A.
    Branas, Charles C.
    Adeoye, Opeolu
    Albright, Karen C.
    Carr, Brendan G.
    NEUROCRITICAL CARE, 2012, 16 (02) : 232 - 240
  • [35] Pediatric neurocritical care
    Bruns, Nora
    Schara-Schmidt, Ulrike
    Dohna-Schwake, Christian
    NERVENARZT, 2023, : 75 - 83
  • [36] Prognosis in neurocritical care
    Puybasset, Louis
    Velly, Lionel
    Audibert, Gerard
    Duracher-Gout, Caroline
    Chevignard, Mathilde
    ANESTHESIE & REANIMATION, 2020, 6 (01): : 122 - 130
  • [37] Osmotherapy in neurocritical care
    Anish Bhardwaj
    Current Neurology and Neuroscience Reports, 2007, 7 : 513 - 521
  • [38] Pediatric Neurocritical Care
    Murphy, Sarah
    NEUROTHERAPEUTICS, 2012, 9 (01) : 3 - 16
  • [39] Neuroprotection in neurocritical care
    Kollmar, Rainer
    MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, 2019, 114 (07) : 635 - 641
  • [40] Neurocritical Care Quality Improvement Practices: A Survey of Members of the Neurocritical Care Society
    Abhijit V. Lele
    Asma M. Moheet
    Neurocritical Care, 2020, 32 : 295 - 301